Independent of Nephrectomy, Weaning Immunosuppression Leads to Late Sensitization After Kidney Transplant Failure

被引:82
作者
Augustine, Joshua J. [1 ]
Woodside, Kenneth J. [2 ]
Padiyar, Aparna [1 ]
Sanchez, Edmund Q. [2 ]
Hricik, Donald E. [1 ]
Schulak, James A. [2 ]
机构
[1] Univ Hosp Case Med Ctr, Dept Med, Cleveland, OH 44106 USA
[2] Univ Hosp Case Med Ctr, Dept Surg, Cleveland, OH 44106 USA
关键词
Kidney transplantation; Immunosuppression; Alloantibody sensitization; RENAL-TRANSPLANT; ALLOGRAFT; SURVIVAL; DIALYSIS; ANTIBODY; STATE;
D O I
10.1097/TP.0b013e3182612921
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Patients returning to dialysis therapy after renal transplant failure have a high rate of human leukocyte antigen antibody sensitization, and sensitization has been linked to allograft nephrectomy. We hypothesized that nephrectomy for cause is a consequence of weaning immunosuppression and that weaning leads to sensitization even in the absence of nephrectomy. Methods. We examined outcomes in 300 consecutive patients with kidney allograft failure and survival of more than 30 days after failure. We analyzed a subset of 119 patients with a low panel reactive antibody (PRA) before transplantation and follow-up PRA testing at 6 to 24 months after failure (late PRA). Results. By late PRA testing, 56% of patients were highly sensitized (class I or II PRA >= 80%). On multivariate analysis controlling for human leukocyte antigen matching, allograft nephrectomy, and other variables, weaning of immunosuppression predicted high sensitization (odds ratio, 14.34; P=0.004). In a subset of patients, the percentage of those who were highly sensitized increased from 21% at the time of failure on immunosuppressive therapy to 68% by late PRA after weaning (P<0.001). Conversely, patients who maintained immunosuppression showed minimal sensitization after failure. Transplant nephrectomy was required in 41% of patients who weaned immunosuppression versus 0% of the 24 patients who maintained immunosuppression with calcineurin inhibitor therapy after failure (P<0.001). Conclusions. Weaning immunosuppression was a triggering event leading to late rejection and allograft nephrectomy and was an independent predictor of alloantibody sensitization after kidney allograft failure.
引用
收藏
页码:738 / 743
页数:6
相关论文
共 18 条
[1]   Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches [J].
Adeyi, OA ;
Girnita, AL ;
Howe, J ;
Marrari, M ;
Awadalla, Y ;
Askar, M ;
Martell, J ;
Zeevi, A ;
Shapiro, R ;
Nalesnik, M ;
Randhawa, P ;
Demetris, AJ ;
Duquesnoy, RJ .
TRANSPLANT IMMUNOLOGY, 2005, 14 (01) :53-62
[2]   At the peril of dialysis patients: Ignoring the failed transplant [J].
Ayus, JC ;
Achinger, SG .
SEMINARS IN DIALYSIS, 2005, 18 (03) :180-184
[3]   Transplant Nephrectomy Improves Survival following a Failed Renal Allograft [J].
Ayus, Juan Carlos ;
Achinger, Steven G. ;
Lee, Shuko ;
Sayegh, Mohamed H. ;
Go, Alan S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (02) :374-380
[4]   The failed renal transplant: In or out? [J].
Bennett, WM .
SEMINARS IN DIALYSIS, 2005, 18 (03) :188-189
[5]  
Gregoor PJHS, 2001, CLIN TRANSPLANT, V15, P397
[6]   Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: Results of a decision analysis [J].
Jassal, SV ;
Lok, CE ;
Walele, A ;
Bargman, JM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (01) :178-183
[7]   Prevention of sepsis during the transition to dialysis may improve the survival of transplant failure patients [J].
Johnston, Olwyn ;
Zalunardo, Nadia ;
Rose, Caren ;
Gill, John S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (04) :1331-1337
[8]   Death after graft loss: An important late study endpoint in kidney transplantation [J].
Kaplan, B ;
Meier-Kriesche, HU .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (10) :970-974
[9]  
Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549
[10]   The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome [J].
Khakhar, AK ;
Shahinian, VB ;
House, AA ;
Muirhead, N ;
Hollomby, DJ ;
Leckie, SH ;
McAlister, VC ;
Chin, JL ;
Jevnikar, AM ;
Luke, PPW .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) :862-863